41
THE FUTURE OF PHARMACY
VOL 28, NO.1 - JUNE 2012
Conclusion w i t h o nl y a n a v e r a g e of 8 .3 m o nt h s , p h a r m a c i s t s we r e a b l e UPEFDSFBTFUIFOVNCFSPG01%DMJOJDWJTJUCZ EFDSFBTF t h e t ot a l OPD he a l t h c a r e e x p e n d i t u r e by NT$1 2 , 6 6 0 , 5 5 2 a n d t h e t ot a l OPD dr ug e x p e n d i t u r e s by NT$ 4 , 6 67, 8 1 6 fo r a ll 8 0 8 p a t i e nt s . W it h t h e co s t- b e n e fi t of 1 : 3 .3 , a lt h o u g h we di d n ot m e e t t h e go a l of de c r e a s e t ot a l h e a l t h c a r e e x p e n d i t u r e by UIFQPTJUJWFSFTVMUTBSFTUJMMWFSZDPOWJODJOH5IFSFTVMUT m a d e t h e a d v i s o r y co m m i t t e e of t h e BNHI to sug g e s t co n - t i n u a t i o n of t h e p r o j e c t , a n d ha v e t h e s e r v i c e e v e n e x p a n d e d t o t h e wh o l e Ta i w a n Isl a n d . More e v i d e n c e s a r e n e e d e d t o p r e s e nt t h e v a l u e of p h a r m a c i s t ’ s p r of e s s i o n a l p r a c t i c e , Ta i w a n p h a r m a c i s t s wo u l d lik e t o co nt r i b u t e t h e i r ef f o r t s in p r ot e c t i n g t h e s a f e a n d a p p r o p r i a t e us e of m e d i c a t i o n by t h e s o c i e t y.
AUTHORS’ INFORMATION
Yen-Huei Tarn, Meng-lin L. Lin , Center for Pharmaceutical Care Development Taiwan Pharmacist Association
REFERENCES 1 . Heple r CD, St r a n d L M .
Oppor t un i t i e s a n d re s p o n s i b i l i t i e s in ph a r m a c e u t i c a l c a r e . American Journal of Hospital Pharmacy, 1990;47:533–43.
2 . ASHP st at e m e nt on ph a r m a c e u t i c a l c a r e . Am J Hosp Pharm. 1993;50:1720-3.
3 . C i p o l l e RJ, St r a n d L M , Mo r l e y P C . Phar m a c e u t i c a l Care Prac t i c e – T h e Clini c i a n ’s Gui d e 2nd Ed. McGraw-Hill: New York 2004.
4 . W i e d e n m a y e r K , Sum m e r s RS, Ma c k i e C A , G o u s AG S , Ever a r d M , Tromp D. D e v e l o p i n g p h a r m a c y p r a c t i c e – A fo cu s on p at i e nt c a r e . Handb o o k – 2006 edition. Geneva: World Health Organiza- tion. 2006.
5 . Go o d Pha r m a c y Prac t i c e 2 0 1 1 . at : http://www.fip.org/files/ fip/WHO/GPP%20guidelines%20FIP%20publication_final.pdf
6 . Ta i w a n Pha r m a c i s t Act 2 0 0 9 - 1 2 -2 8 . No. 16, accessed on November 23, 2011 . http://www.fda.gov. tw/eng/people_laws_list.aspx
7. Tarn YH. St a n d a r d s of pr a c t i c e fo r ph a r m a c e u t i c a l c a r e . The Journal of Taiwan Pharmacy. 2010;26:S33-S8.
8 . Tarn YH. Patie nt c a r e pr o c e s s . The Journal of Taiwan Pharmacy. 2010;26:S59-S69.
9 . Tarn YH. I m p l e m e nt a t i o n of le v e l II t r a i n i n g co ur s e s fo r ph a r m a c i s t s p r a c t i c i n g in lo n g - t e r m c a r e . The Journal of Long-term Care. 2011;15:107-14.
1 0 . SF -3 6 ge t p e r m i s s i o n here 1 1 . EQ - 5D ge t p e r m i s s i o n f r o m User Sup p o r t Office r & Juni o r
Rese a r c h e r Euro Q o l Exe cut i v e Office : http://www.euroqol. org/